Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity. (Q37258295)
Jump to navigation
Jump to search
scientific article published on 28 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity. |
scientific article published on 28 March 2013 |
Statements
Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity (English)
Miriam Lipiski
Jin Hyen Baek
Wolfgang R Engelsberger
Paul W Buehler
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference